Third, experimental validation in vivo and in vitro focusing on the suppressive effects of two potential active compounds of G. pentaphyllum, quercetin and rhamnazin, on NSCLC cells as well as the expressions of MYC, ESR1, and HIF1A is warranted to improve the preliminary nature of the study. The gene discussed is HIF1A; the disease is non-small cell lung carcinoma.